A study evaluating the impact of genetic variability of GLP-1R on weight response to liraglutide demonstrated that some polymorphisms are associated with individual differences regarding weight loss response in obese women with PCOS. The gene discussed is GLP1R; the disease is polycystic ovary syndrome.